Q1 2021

Filed May 17, 2021 · 10-Q · 47 days after period end · 0001477932-21-003305

Q1 2021 · 10-Q

Revenue

$10.12K

−72.6% vs Q1 2020

Net Income

-$1.58M

N/M vs Q1 2020

EPS Diluted

-$0.26

N/M vs Q1 2020

Operating Income-$1,579,216N/M

Operating Cash Flow

Same quarter

Metric	Q1 2021	Q1 2020	Q1 2019	Q1 2018
Revenue	$10.12K	$36.90K	$65.27K	$147.72K
Net Income	-$1.58M	-$1.08M	-$1.77M	-$1.00M
EPS Diluted	-$0.26	-$0.20	-$0.67	-$0.41

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

BioCorRx Inc. · CIK 1443863 · Engraved from SEC EDGAR